The BalancedInvestor Club

SBFMW Market Analysis

Overview

Fundamentals

P/E ratio—
EPS (TTM)$-2.210.0% YoY
Profit margin-17.0%
Market cap—

Valuation

Forward P/E
—
PEG ratio
—
P/B
—
P/S (TTM)
—
EV/EBITDA
—

Profitability & growth

ROE (TTM)
-27.3%
Operating margin
-17.2%
Revenue growth YoY
-9.1%
Dividend yield
—
Beta
1.49

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About Sunshine Biopharma Inc. Warrant

Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the development of anticancer drugs. The company is headquartered in Pointe-Claire, Canada.

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
333 LAS OLAS WAY, FORT LAUDERDALE, FL
Fiscal year end
December
Latest quarter
Mar 31, 2026
Shares outstanding$0
52W high$0.42
52W low$0.03

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer